wiki pageCreated: 2026-04-02T07:19:08By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-kcnma1-protein
📖 Wiki Page
protein934 wordssynced 2026-04-02
KCNMA1 Protein (BK Channel)
Introduction
Kcnma1 Protein (Bk Channel) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
KCNMA1 encodes the alpha subunit of the large-conductance calcium-activated potassium channel (BK channel), also known as Slo1 or MaxiK. BK channels are unique among potassium channels in their dual activation by voltage and intracellular calcium, making them critical regulators of cellular excitability in [neurons](/entities/neurons), smooth muscle cells, and many other cell types.
Structure
BK channels have a distinctive architecture:
...
KCNMA1 Protein (BK Channel)
Introduction
Kcnma1 Protein (Bk Channel) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
KCNMA1 encodes the alpha subunit of the large-conductance calcium-activated potassium channel (BK channel), also known as Slo1 or MaxiK. BK channels are unique among potassium channels in their dual activation by voltage and intracellular calcium, making them critical regulators of cellular excitability in [neurons](/entities/neurons), smooth muscle cells, and many other cell types.
Structure
BK channels have a distinctive architecture:
Seven Transmembrane Domains: S0-S6, with S1-S4 forming the voltage sensor
Auditory Function: Critical for inner ear hair cell repolarization
Hormone Secretion: Modulates Ca²⁺ entry in endocrine cells
Role in Disease
Neurodegenerative Diseases
Alzheimer's Disease:
BK channel dysfunction affects neuronal Ca²⁺ handling
Altered channel expression in AD brain
May contribute to synaptic dysfunction
Parkinson's Disease:
May affect dopaminergic neuron survival
Altered excitability in PD models
Epilepsy:
Some variants alter seizure threshold
Neuronal BK channel dysfunction contributes to hyperexcitability
Other Conditions
Dystonia: Associated with certain KCNMA1 variants
Hypertension: Vascular BK channel dysfunction
Arrhythmias: Cardiac BK channel role in repolarization
Therapeutic Targeting
BK channels are drug targets for multiple conditions:
| Condition | Drug | Status | Notes | |-----------|------|--------|-------| | Stroke | BMS-191011 | Research | Neuroprotective | | Hypertension | Various | Research | Vasodilators | | Urinary Incontinence | Various | Research | Bladder relaxants | | Epilepsy | Various | Research | Anticonvulsant potential |
Key Publications
Marty A et al. (1984). Large conductance Ca²⁺-activated K⁺ channels. Nature 309(5966): 354-356. PMID: 6325494(https://pubmed.ncbi.nlm.nih.gov/6325494/)
Sah P, Davies P (2000). Calcium-activated potassium channels in neuronal excitability. Annu Rev Physiol 62: 107-129. PMID: 10645072(https://pubmed.ncbi.nlm.nih.gov/10645072/)
Background
The study of Kcnma1 Protein (Bk Channel) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Multiple splice variants with different properties
Stress-regulated splicing
Tissue-specific expression patterns
Ion Selectivity and Conductance
Highly selective for potassium ions (PK/PNa > 100)
Single channel conductance of ~250-300 pS
One of the largest conductance ion channels known
Fast activation and deactivation kinetics
Neurodegeneration Mechanisms
Alzheimer's Disease
BK channels in Alzheimer's disease show several alterations:
[@expression]: Expression Changes: Altered KCNMA1 expression in AD brain tissue [@calcium]: Calcium Dysregulation: Impaired calcium sensing affects channel function [@synaptic]: Synaptic Dysfunction: BK channel alterations contribute to synaptic hyperexcitability [@therapeutic]: Therapeutic Potential: BK channel modulators may protect against amyloid toxicity
Parkinson's Disease
Dopaminergic neurons show altered BK channel activity
Channel dysfunction may contribute to neuronal death
Potential for neuroprotective strategies
Therapeutic Strategies
Channel Openers
BMS-191011: Neuroprotective in stroke models
NS-1619: Investigated for neuroprotection
Natural compounds: Flavonoids, terpenoids
Channel Blockers
Paxilline: Research tool, potential anticonvulsant
IbTX: Scorpion toxin, research use
Clinical Relevance
Genetic Disorders
KCNMA1-linked Ataxia: Associated with movement disorders
Developmental Delays: Some variants cause neurological symptoms
Seizure Disorders: Altered excitability from channel dysfunction